04:11
Unknown
Aurobindo Pharma is reportedly in discussion with global pharma giant Actavis to buy their Active Pharmaceutical Ingredients (API) units in Western Europe. The move is in line with the Aurobindo’s strategy to vertically integrate their injectables business by buying ingredient making units.
Posted in: Indian Market Tips
0 comments:
Post a Comment